Duchesnay
Guillaume Ouellet is an experienced professional in regulatory affairs with a strong background in drug development. Currently serving as a Regulatory Affairs Associate at Duchesnay since August 2021, Ouellet has also held similar positions at Servier and Pharmascience, contributing expertise in international regulatory affairs and CMC. Ouellet began regulatory affairs work as an intern at Servier and gained foundational experience as a Technical Assistant in Pharmacy at Groupe Jean Coutu. Academically, Ouellet holds a Master's degree in Drug Development, a DESS in Drug Development, and a Bachelor's degree in Chemistry, all from Université de Montréal.
This person is not in the org chart
This person is not in any offices
Duchesnay
The multinational Duchesnay with its affiliated companies is headquartered in Blainville, Quebec. The group consists of five pharmaceutical companies to meet the needs of patients in Canada, the U.S. and abroad: - Duchesnay (Canada) and Duchesnay USA, both dedicated to women’s health; - Médunik Canada and Medunik USA, which provide treatments for rare diseases; and - Analog Pharma, an American generic drugs company, specializing in authorized generics and orphan drugs. From its state-of-the-art manufacturing plant in Blainville, Quebec, Duchesnay exports its innovative treatments to more than 50 countries. Duchesnay and Medunik, through their proprietary research and development, and through partnerships, offer innovative treatments for a variety of medical conditions in women’s health, urology, oncology as well as for rare diseases. The group of companies recognizes the dedication and professionalism of its employees and promotes a positive work culture and flexible work environment. It is deeply committed to environmental responsibility and giving back to the community through the support of various charitable organizations.